Zim Laboratories H1FY27 Results (NSE: ZIMLAB)
Signal: Loss widened
The read
The top-line inflected positively with H1 revenue up 24.4% YoY to ₹19,962.41 lakh, but the recovery is not yet earnings-quality positive: EBITDA margin contracted 229bps to 3.95%, finance costs rose 17.3% to ₹758.09 lakh, operating cash flow fell to ₹126.93 lakh from ₹1,991.76 lakh, and PAT remained a ₹606.63 lakh loss.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹199.62 Cr | +24.4% | N/A |
| EBIT | ₹-4.02 Cr | -2498.5% | |
| Net profit | ₹-6.07 Cr | -163.8% | |
| EPS | ₹-1.13 | Loss per share widened 140.4% | |
| EBIT margin | 3.95% |
P&L walk
Consolidated revenue increased 24.4% YoY to ₹19,962.41 lakh, but EBITDA margin declined 229bps to 3.95% as employee and other expenses rose faster than sales; depreciation increased 20.9% and the group reported a ₹606.63 lakh PAT loss.
Key positives
- Consolidated revenue increased 24.4% YoY to ₹19,962.41 lakh, reversing the prior-year H1 weakness, while standalone revenue rose 23.4% to ₹19,727.14 lakh.
- Property, plant and equipment increased to ₹17,834.54 lakh from ₹15,643.23 lakh alongside ₹2,660.25 lakh of H1 capex, indicating continued investment in the asset base.
- Consolidated and standalone PAT were closely aligned at losses of ₹606.63 lakh and ₹601.69 lakh respectively, so subsidiaries did not materially dilute the parent's earnings outcome.
Key concerns
- EBITDA margin declined to 3.95% from 6.24% despite 24.4% revenue growth, with other expenses rising 31.6% YoY to ₹6,562.37 lakh.
- PAT loss widened to ₹606.63 lakh from ₹229.95 lakh and EBIT moved to a ₹402.45 lakh loss from ₹16.78 lakh profit.
- Finance costs rose 17.3% to ₹758.09 lakh while borrowings increased to ₹14,615.43 lakh, raising leverage pressure during a loss-making period.
- Operating cash flow fell to ₹126.93 lakh from ₹1,991.76 lakh while capex increased to ₹2,660.25 lakh, leaving investment spending materially ahead of internally generated cash.
Research and educational content only. Not investment advice.